These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11665831)

  • 1. Efficacy of different antiepileptic drugs in children with Angelman syndrome associated with 15q11-13 deletion: the Danish experience.
    Ostergaard JR; Balslev T
    Dev Med Child Neurol; 2001 Oct; 43(10):718-9. PubMed ID: 11665831
    [No Abstract]   [Full Text] [Related]  

  • 2. Seizure treatment in Angelman syndrome: A case series from the Angelman Syndrome Clinic at Massachusetts General Hospital.
    Shaaya EA; Grocott OR; Laing O; Thibert RL
    Epilepsy Behav; 2016 Jul; 60():138-141. PubMed ID: 27206232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of vigabatrin in Angelman syndrome.
    Kuenzle C; Steinlin M; Wohlrab G; Boltshauser E; Schmitt B
    Epilepsia; 1998 Nov; 39(11):1213-5. PubMed ID: 9821987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angelman syndrome associated with a maternal 15q11-13 deletion of less than 200 kb.
    Buxton JL; Chan CT; Gilbert H; Clayton-Smith J; Burn J; Pembrey M; Malcolm S
    Hum Mol Genet; 1994 Aug; 3(8):1409-13. PubMed ID: 7987324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion involving D15S113 in a mother and son without Angelman syndrome: refinement of the Angelman syndrome critical deletion region.
    Michaelis RC; Skinner SA; Lethco BA; Simensen RJ; Donlon TA; Tarleton J; Phelan MC
    Am J Med Genet; 1995 Jan; 55(1):120-6. PubMed ID: 7702085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant somatosensory-evoked responses imply GABAergic dysfunction in Angelman syndrome.
    Egawa K; Asahina N; Shiraishi H; Kamada K; Takeuchi F; Nakane S; Sudo A; Kohsaka S; Saitoh S
    Neuroimage; 2008 Jan; 39(2):593-9. PubMed ID: 17962046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epilepsy in patients with angelman syndrome caused by deletion of the chromosome 15q11-13.
    Valente KD; Koiffmann CP; Fridman C; Varella M; Kok F; Andrade JQ; Grossmann RM; Marques-Dias MJ
    Arch Neurol; 2006 Jan; 63(1):122-8. PubMed ID: 16401744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental outcome in Angelman syndrome: genotype-phenotype correlations.
    Mertz LG; Thaulov P; Trillingsgaard A; Christensen R; Vogel I; Hertz JM; Ostergaard JR
    Res Dev Disabil; 2014 Jul; 35(7):1742-7. PubMed ID: 24656292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the characteristics of epilepsy in 37 patients with the molecular diagnosis of Angelman syndrome.
    Galván-Manso M; Campistol J; Conill J; Sanmartí FX
    Epileptic Disord; 2005 Mar; 7(1):19-25. PubMed ID: 15741136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent germline mosaicism for a 15q11-q13 deletion causing recurrent Angelman syndrome in a Chinese family.
    Tang HS; Wang DG; Xie XM; Li DZ
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():255-257. PubMed ID: 30890277
    [No Abstract]   [Full Text] [Related]  

  • 11. Lamotrigine effect on GABA transmission in Angelman syndrome?
    Dan B; Boyd SG; Pelc K; Cheron G
    Epilepsia; 2007 Aug; 48(8):1634. PubMed ID: 17692055
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular study of chromosome 15 in 22 patients with Angelman syndrome.
    Beuten J; Mangelschots K; Buntinx I; Coucke P; Brouwer OF; Hennekam RC; Van Broeckhoven C; Willems PJ
    Hum Genet; 1993 Jan; 90(5):489-95. PubMed ID: 8094063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in methylation patterns within the D15S9 region of chromosome 15q11-13 in first cousins with Angelman syndrome and Prader-Willi syndrome.
    Clayton-Smith J; Driscoll DJ; Waters MF; Webb T; Andrews T; Malcolm S; Pembrey ME; Nicholls RD
    Am J Med Genet; 1993 Oct; 47(5):683-6. PubMed ID: 8266996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropsychiatric phenotype of Angelman syndrome and clinical care: report of seven cases].
    Cote-Orozco JE; Mera-Solarte PD; Espinosa-García E
    Arch Argent Pediatr; 2017 Apr; 115(2):e99-e103. PubMed ID: 28318193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angelman syndrome and pseudo-hypsarrhythmia: a diagnostic pitfall.
    Darteyre S; Mazzola L; Convers P; Lebrun M; Ville D
    Epileptic Disord; 2011 Sep; 13(3):331-5. PubMed ID: 21865124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supernumerary inv dup(15) in a patient with Angelman syndrome and a deletion of 15q11-q13.
    Spinner NB; Zackai E; Cheng SD; Knoll JH
    Am J Med Genet; 1995 May; 57(1):61-5. PubMed ID: 7645601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of human induced pluripotent stem cell line from a patient with Angelman syndrome carrying the deletion of maternal chromosome 15q11.2-q13.
    Niki T; Imamura K; Enami T; Kinoshita M; Inoue H
    Stem Cell Res; 2019 Jan; 34():101363. PubMed ID: 30605843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eating behavior, prenatal and postnatal growth in Angelman syndrome.
    Mertz LG; Christensen R; Vogel I; Hertz JM; Østergaard JR
    Res Dev Disabil; 2014 Nov; 35(11):2681-90. PubMed ID: 25064682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype-genotype correlation in 20 deletion and 20 non-deletion Angelman syndrome patients.
    Moncla A; Malzac P; Voelckel MA; Auquier P; Girardot L; Mattei MG; Philip N; Mattei JF; Lalande M; Livet MO
    Eur J Hum Genet; 1999; 7(2):131-9. PubMed ID: 10196695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are specific short arm variants or heteromorphisms over-represented in the chromosome 15 deletion in Angelman or Prader-Willi syndrome patients?
    Butler MG
    Am J Med Genet; 1994 Mar; 50(1):42-5. PubMed ID: 8160752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.